GD analyst, Vinie Varkey notes that tozorakimab could capture a "significant patient share" as an add-on therapy in COPD.

Scott Brooks, from Maltby, was just 17 when he started smoking, saying it was just "the norm" for the 1980s. But after ...

Select your location to view local American Lung Association events and news near you.

Liraglutide reduced obstructive sleep apnea severity and improved quality of life in patients with overweight or obesity and ...

Use of CT is proven to save lives in patients eligible for lung cancer screening, which includes most patients with COPD, said Barr, professor of medicine and epidemiology at Columbia University ...

Top-line results from the OBERON and TITANIA trials showed that tozorakimab reduced the annualised rate of moderate-to-severe ...

A cough, at its simplest, is a reflex. Your body’s built-in way of clearing the airways when something feels off. Dust, mucus, smoke, or infection, anything that irritates the throat or lungs can ...

AstraZeneca jumps 4% after COPD drug wins Phase 3 trials. Tozorakimab success seen as rare win in tough COPD drug race. Strong trial data boosts AstraZeneca’s long-term revenue outlook. Shares of ...

Adding as little as 1,700 to 5,500 steps per day can offset the risk of a list of chronic diseases—including obesity, ...

Russell Winwood's chronic obstructive pulmonary disease (COPD) diagnosis in 2011 was a brutal wake-up call. His second in less than a decade. The Brisbane native, who came to be known as the “COPD ...

AstraZeneca shares were up about 3.5% Friday after the company said its drug for COPD, a deadly lung disease often caused by smoking, slowed patients' symptoms in two large trials. The drug, ...

Extrafine single-inhaler triple therapy with BDP/FF/GB is effective for improving health-related quality of life and lung function in COPD.